Tesla第三季交車量未達標 於中國改良Model Y不加價
Tesla(TSLA.US)周一(2日)最新公布今年第三季總交車量為435,059輛,少於第二季的466,140輛,亦低於市場預期的45萬輛;總產量為430,488輛,亦少於第二季的479,700輛,同時低於市場預期的43萬輛。
Tesla稱,銷量連續下跌是由於工廠升級及停工造成,但今年約180萬輛汽車的銷量目標保持不變。
同時,Tesla於中國發布「Model Y」的升級版,其配置有所改進,但售價不變,以應對比亞迪(01211.HK)等國內競爭對手的不斷升級及價格壓力。
Tesla於其微信帳戶上發文稱,升級版的變化包括0至100公里/小時加速時間稍快5.9秒、車輪設計更新和增加照明,新改良Model Y基本型號的起價仍為263,900元人民幣。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.